Charming Medical Ltd. (MCTA) shares shot up to $8.21 – slightly more than double their IPO price – in their NASDAQ debut today – Tuesday, Oct. 21, 2025. The Hong Kong provider of TCM-inspired therapies and products priced its micro-cap IPO at $4.00 last night (Monday, Oct. 20, 2025) on 1.6 million shares to raise $6.4 million. The IPO was priced at the low end of the deal’s $4.00-to-$6.00 price range.
Cathay Securities was the sole book-runner.
Charming Medical’s stock closed at $7.00 – up $3.00 from their IPO price for a gain of 75 percent in their first day of NASDAQ trading – on volume of abut 4.18 million shares on Tuesday, Oct. 21, 2025. Shares of Charming Medical opened at $4.59 – up 59 cents from their IPO price – on NASDAQ volume of 95,793 shares.
Charming Medical Ltd. offers beauty, wellness and postpartum products and services for women at its four wellness centers in Hong Kong. This part of the business is conducted under the Beauty Lab Group brand. The products and services are influenced by the principles and practices of Traditional Chinese Medicine (TCM). Some are designed to relieve PMS, menstrual irregularities and PID (pelvic inflammatory disease), while other products and services are offered to promote breast health, provide menopausal care or to address other common women’s health conditions, according to the prospectus.
Charming Medical also provides some products and services tailored to men, the prospectus said.
The company is profitable, according to financial statements in the prospectus. Charming Medical Ltd. reported net income of $1.2 million on revenue of $6.2 million for the 12 months that ended March 31, 2025.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading.
The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and the rating is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.